Ind-Swift Laboratories Limited announced a private placement that it will issue up to 26,000,000 convertible warrants Convertible into equivalent number of Equity Shares of INR 10 each within a maximum period of 18 months from the date of allotment of such Warrants on June 27, 2024. The transaction will include participation from new investors such as Essix Biosciences Limited; Hcp Investments; Zeal Global Opportunities Fund and Saral Incorporated VCC Sub Fund 1. The issue price maybe determined by the Board/ Committee of Directors in accordance with provisions of Chapter V of SEBI ICDR Regulations, as amended and applicable provisions of the Companies Act, 2013.